Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

南京臣功制药股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8mdl5TesAHG
Approval Number: 国药准字H20256447
Generic Name: 达格列净二甲双胍缓释片(Ⅰ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含达格列净10mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg
Reg Date: 2025-12-30
Company Name: 南京臣功制药股份有限公司
Company Address: 南京经济技术开发区新港大道20号
Production Company Name: 以岭万洲国际制药有限公司
Production Company Address: 河北省石家庄市高新区珠江大道36号
Company Detail Path: /organization/nan-jing-chen-gong-zhi-yao-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/yi-ling-mo-zhou-guo-ji-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 30, 2025

Approval ID

8mdl5TesAHG

Type

化学药品